Detecting presymptomatic disease in inherited frontotemporal dementia

检测遗传性额颞叶痴呆的症状前疾病

基本信息

项目摘要

Project Summary/Abstract This is an application for a K23 award for Dr. Suzee Lee, a behavioral neurologist at the University of California, San Francisco (UCSF). Dr. Lee is establishing herself as a young investigator in patient-oriented clinical research of neurodegenerative disorders. This K23 award will provide Dr. Lee with the support necessary to accomplish the following goals: (1) to become an expert at patient-oriented clinical research in frontotemporal dementia (FTD); (2) to conduct clinical investigations of presymptomatic carriers of genes implicated in FTD; (3) to implement novel and advanced neuroimaging techniques in clinical studies; and (4) to develop an independent clinical research career. To achieve these goals, Dr. Lee has assembled a mentoring team comprised of two co-primary mentors. Dr. Bruce Miller, clinical director of the UCSF Memory and Aging Center (MAC), directs a program project grant on FTD (FTD-PPG) and a Hillblom Aging Network grant to study normal aging. Dr. William Seeley, director the UCSF MAC Autopsy Program and the Neuropathology Core, conducts neuroimaging studies on selective vulnerability in neurodegenerative diseases to explore early-stage disease pathogenesis. The mentoring team also includes two collaborators: Dr. Maria-Luisa Gorno-Tempini, a neurologist who focuses on neuroimaging in primary progressive aphasia and Dr. John Neuhaus, a statistician, who is an expert in study design and biostatistical analysis. Early diagnosis of frontotemporal dementia is notoriously challenging. Dr. Lee's research will focus on detecting vulnerable brain networks in presymptomatic carriers of FTD gene mutations (Aims 1 and 2). Dr. Lee will use the existing infrastructure and subject cohorts of the FTD-PPG and Hillblom Aging Network to study 50 unaffected family members of probands with FTD to determine the effect of FTD-related genes on alterations in large-scale structural and functional connectivity neural networks. This research will be the first step in a series of investigations that will aid the longitudinal characterization of the natural history of FTD from its earliest stages, paving the way for the field to establish disease monitoring strategies and time points for future treatments in gene mutation carriers.
项目概要/摘要 这是纽约大学行为神经学家 Suzee Lee 博士的 K23 奖学金申请 加利福尼亚州、旧金山 (UCSF)。李博士正在将自己打造成以患者为中心的年轻研究者 神经退行性疾病的临床研究。这个K23奖项将为李博士提供支持 实现以下目标所必需的:(1)成为以患者为中心的临床研究专家 额颞叶痴呆(FTD); (二)对症状前基因携带者进行临床调查 涉及 FTD; (3) 在临床研究中应用新颖、先进的神经影像技术; (4) 至 发展独立的临床研究生涯。为了实现这些目标,李博士组建了一个指导团队 团队由两名联合主要导师组成。 Bruce Miller 博士,加州大学旧金山分校记忆与衰老临床主任 中心 (MAC),指导 FTD 计划项目拨款 (FTD-PPG) 和 Hillblom 老龄化网络拨款进行研究 正常老化。 William Seeley 博士,加州大学旧金山分校 MAC 尸检项目和神经病理学核心主任, 对神经退行性疾病的选择性脆弱性进行神经影像学研究,以探索早期阶段 疾病发病机制。指导团队还包括两名合作者:Maria-Luisa Gorno-Tempini 博士, 专注于原发性进行性失语症神经影像学的神经学家和统计学家 John Neuhaus 博士, 他是研究设计和生物统计分析方面的专家。 额颞叶痴呆的早期诊断非常具有挑战性。李博士的研究重点是 检测 FTD 基因突变症状前携带者的脆弱大脑网络(目标 1 和 2)。李博士 将利用 FTD-PPG 和 Hillblom 老龄化网络的现有基础设施和受试者群体来研究 50 患有 FTD 的先证者未受影响的家庭成员,以确定 FTD 相关基因对改变的影响 大规模结构和功能连接神经网络。这项研究将是迈出的第一步 一系列的研究将有助于从 FTD 的角度纵向描述 FTD 的自然历史 最早阶段,为该领域制定未来疾病监测策略和时间点铺平道路 基因突变携带者的治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUZEE EURIE LEE其他文献

SUZEE EURIE LEE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUZEE EURIE LEE', 18)}}的其他基金

Neurodevelopment in children from families with genetic frontotemporal dementia and Alzheimer’s disease
遗传性额颞叶痴呆和阿尔茨海默病家族儿童的神经发育
  • 批准号:
    10364525
  • 财政年份:
    2022
  • 资助金额:
    $ 15.24万
  • 项目类别:
Neurodevelopment in children from families with genetic frontotemporal dementia and Alzheimer's disease
遗传性额颞叶痴呆和阿尔茨海默病家庭儿童的神经发育
  • 批准号:
    10632707
  • 财政年份:
    2022
  • 资助金额:
    $ 15.24万
  • 项目类别:
Neurodevelopment in children from families with genetic frontotemporal dementia and Alzheimer’s disease
遗传性额颞叶痴呆和阿尔茨海默病家族儿童的神经发育
  • 批准号:
    10571880
  • 财政年份:
    2022
  • 资助金额:
    $ 15.24万
  • 项目类别:
Neurodevelopment in children from families with genetic frontotemporal dementia and Alzheimer’s disease
遗传性额颞叶痴呆和阿尔茨海默病家族儿童的神经发育
  • 批准号:
    10810931
  • 财政年份:
    2022
  • 资助金额:
    $ 15.24万
  • 项目类别:
Defining trajectories of dynamic biomarkers for C9ORF72 repeat expansion carriers
定义 C9ORF72 重复扩增载体动态生物标志物的轨迹
  • 批准号:
    9922197
  • 财政年份:
    2018
  • 资助金额:
    $ 15.24万
  • 项目类别:
Defining trajectories of dynamic biomarkers for C9ORF72 repeat expansion carriers
定义 C9ORF72 重复扩增载体动态生物标志物的轨迹
  • 批准号:
    9763405
  • 财政年份:
    2018
  • 资助金额:
    $ 15.24万
  • 项目类别:
Defining trajectories of dynamic biomarkers for C9ORF72 repeat expansion carriers
定义 C9ORF72 重复扩增载体动态生物标志物的轨迹
  • 批准号:
    10390317
  • 财政年份:
    2018
  • 资助金额:
    $ 15.24万
  • 项目类别:
Detecting presymptomatic disease in inherited frontotemporal dementia
检测遗传性额颞叶痴呆的症状前疾病
  • 批准号:
    8713890
  • 财政年份:
    2011
  • 资助金额:
    $ 15.24万
  • 项目类别:
Detecting presymptomatic disease in inherited frontotemporal dementia
检测遗传性额颞叶痴呆的症状前疾病
  • 批准号:
    8241501
  • 财政年份:
    2011
  • 资助金额:
    $ 15.24万
  • 项目类别:
Detecting presymptomatic disease in inherited frontotemporal dementia
检测遗传性额颞叶痴呆的症状前疾病
  • 批准号:
    8334081
  • 财政年份:
    2011
  • 资助金额:
    $ 15.24万
  • 项目类别:

相似海外基金

Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
  • 批准号:
    10635325
  • 财政年份:
    2023
  • 资助金额:
    $ 15.24万
  • 项目类别:
In vivo Identification of Pre-Atrophic Brain Neurodegeneration in Prodromal Alzheimer Disease with Quantitative Gradient Recalled Echo MRI
利用定量梯度回忆回波 MRI 体内鉴定阿尔茨海默病前驱期的萎缩前脑神经变性
  • 批准号:
    10448152
  • 财政年份:
    2022
  • 资助金额:
    $ 15.24万
  • 项目类别:
The Development and Rescue of an Atrophic Nonunion Model
萎缩性骨不连模型的开发和挽救
  • 批准号:
    10007577
  • 财政年份:
    2019
  • 资助金额:
    $ 15.24万
  • 项目类别:
The Development and Rescue of an Atrophic Nonunion Model
萎缩性骨不连模型的开发和挽救
  • 批准号:
    10242918
  • 财政年份:
    2019
  • 资助金额:
    $ 15.24万
  • 项目类别:
Analysis of the role of AMPK in the retina for the development of a novel treatment for atrophic age-related macular degeneration
分析 AMPK 在视网膜中的作用,以开发治疗萎缩性年龄相关性黄斑变性的新方法
  • 批准号:
    18K09457
  • 财政年份:
    2018
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regeneration of atrophic salivary glands by reconstructing tissue macrophages using amniotic fluid-derived cells
利用羊水来源的细胞重建组织巨噬细胞来再生萎缩的唾液腺
  • 批准号:
    19K21370
  • 财政年份:
    2018
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
The study to detect early-stage pancreatic cancer based on the data from molecular biology about the atrophic acinar cell surrounding carcinoma in situ.
该研究基于原位癌周围萎缩性腺泡细胞的分子生物学数据来检测早期胰腺癌。
  • 批准号:
    18K07897
  • 财政年份:
    2018
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Multiple control and visualization of self-somatic- stem cells for atrophic jaw bone augmentation
用于萎缩颌骨增量的自体干细胞的多重控制和可视化
  • 批准号:
    17H04394
  • 财政年份:
    2017
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Delivery of concentrated peripheral blood derived EPCs and functional miRNAs for atrophic salivary gland regeneration
输送浓缩的外周血来源的 EPC 和功能性 miRNA 以促进萎缩唾液腺再生
  • 批准号:
    17K17272
  • 财政年份:
    2017
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Development of novel oligonucleotide therapeutics using functional liposomes for atrophic muscular disorder
使用功能性脂质体开发治疗萎缩性肌肉疾病的新型寡核苷酸疗法
  • 批准号:
    16K20646
  • 财政年份:
    2016
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了